Skip to main content

Table 2 Effects of extracellular vesicles in lung diseases

From: Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases?

Study

Model

Origin

Effects

Admyre et al., 2008 [55]

Allergic inflammation

Mast cell-derived EVs

DC maturation, allergen transportation, allergen-specific Th2 cell activation

Bakouboula et al., 2008 [63]

PAH

EVs released from stimulated or endothelial cells undergoing apoptosis

Increase in EVs release is directly related to PAH severity

Prado et al., 2008 [61]

Allergic inflammation

BALF-derived EVs from mice sensitized and challenged with ovalbumin

Inhibition of IgE response, Th2 cytokine production, and airway inflammation

Ionescu et al., 2012 [70]

Endotoxin-induced ARDS

CM from MSC

Increase in secretion of exosomes by MSCs and M2 macrophages, in part via IGF-1

Lee et al., 2012 [65]

Hypoxia-induced PAH

MSC-derived EVs

Reduced right ventricular systolic pressure and right ventricular hypertrophy

Torregrosa et al., 2012 [60]

Coculture of BECs with BALF EVs from asthmatic patients

EVs from BALF of asthmatic patients

Increased leukotriene and IL-8 release

Aliotta et al., 2013 [64]

Monocrotaline-induced PAH

Lung-derived and plasma-derived EVs from monocrotaline-induced PAH

Increased right ventricular mass and pulmonary vascular wall thickness

Zhu et al., 2014 [72]

Escherichia coli endotoxin-induced ARDS

EVs derived from hMSCs

Reduction in extravascular lung water, total protein levels in BALF, edema, neutrophil infiltration, associated with increased KGF expression

Cruz et al., 2015 [62]

Aspergillus hyphal extract-induced allergic inflammation

CM and EVs derived from hMSCs and mMSCs

More significant reduction of airway hyperresponsiveness, lung inflammation and CD4 T-cell Th2 and Th17 phenotype in both CM and EVs from hMSCs compared with mMSCs; inhibition of soluble mediators and EVs release reduced the beneficial effects of all treatments

Monsel et al., 2015 [78]

Escherichia coli pneumonia

MSC and MSC-derived EVs

Improved survival and reduced lung inflammation, protein permeability, and bacterial growth

  1. ARDS acute respiratory distress syndrome, BALF bronchoalveolar lavage fluid, BEC bronchial epithelial cell, CM conditioned medium, DC dendritic cell, EV extracellular vesicle, hMSC human mesenchymal stem cell, IGF-1 insulin-like growth factor-1, IL interleukin, KGF keratinocyte growth factor, MSC mesenchymal stem cell, mMSC mouse mesenchymal stem cell, PAH pulmonary arterial hypertension, Th T-helper